Compare CRBU & MITT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRBU | MITT |
|---|---|---|
| Founded | 2011 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 203.9M | 231.7M |
| IPO Year | 2021 | N/A |
| Metric | CRBU | MITT |
|---|---|---|
| Price | $1.80 | $7.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $10.75 | $9.25 |
| AVG Volume (30 Days) | ★ 983.6K | 325.1K |
| Earning Date | 03-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 12.60% |
| EPS Growth | ★ 3.64 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.63 | $4.09 |
| Revenue Next Year | $10.93 | $4.69 |
| P/E Ratio | ★ N/A | $9.34 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.66 | $5.63 |
| 52 Week High | $3.53 | $9.27 |
| Indicator | CRBU | MITT |
|---|---|---|
| Relative Strength Index (RSI) | 45.36 | 38.00 |
| Support Level | $1.70 | $7.03 |
| Resistance Level | $2.04 | $7.86 |
| Average True Range (ATR) | 0.11 | 0.24 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 3.70 | 12.18 |
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
TPG Mortgage Investment Trust Inc is a real estate investment trust (REIT). It focuses on investing in a diversified risk-adjusted portfolio of residential mortgage-related assets in the U.S. mortgage market. Its objective is to provide attractive risk-adjusted returns to its stockholders over the long term through dividends and capital appreciation. The company focuses on its investment activities on acquiring and securitizing newly-originated residential mortgage loans within the non-agency segment of the housing market.